BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Liu XY, Tang H, Zhou QY, Zeng YL, Chen D, Xu H, Li Y, Tan B, Qian JM. Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology. World J Gastroenterol 2023; 29(2): 272-285 [PMID: 36687128 DOI: 10.3748/wjg.v29.i2.272]
URL: https://www.wjgnet.com/1007-9327/full/v29/i2/272.htm
(189) (201) (0) (0) (7) (6452) (26)
Number Citing Articles
1
Saher Mahmood, Areeba Saeed, Shahid Nawaz, Maira Saleem. The Gut Microbiome in Precision Medicine. 2026;  doi: 10.1016/B978-0-443-40483-2.00022-4
2
A.A. Belousova, E.M. Milchakova, K.I. Ogarkova, S.E. Mustafaeva, E.S. Bagdasarova, E.N. Abdullaeva, A.A. Churochkin, Z.A. Kalakutok, S.V. Agaloyan, A.A. Makaeva. Modern high-tech approaches to the diagnosis of gastrointestinal diseases. CARDIOMETRY 2024; (31) doi: 10.18137/cardiometry.2024.31.4046
3
Fatima Soufan, Abir Ghosson, Rayyan Jaber, Adel Ghandour, Olivier Uwishema. The Gut‐Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention—A Narrative Review. Health Science Reports 2025; 8(4) doi: 10.1002/hsr2.70660
4
Danny Con, Peter De Cruz. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2023.00175
5
Philippe Pinton. Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2300670
6
Gowthami Sai Kogilathota Jagirdhar, Jose Andres Perez, Andrea Belen Perez, Salim Surani. Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease. World Journal of Gastroenterology 2023; 29(36): 5211-5225 doi: 10.3748/wjg.v29.i36.5211
7
Ruoyi Gan, Enqi Ni, Guanyue Li, Wei Chen. A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms. MedComm – Biomaterials and Applications 2025; 4(3) doi: 10.1002/mba2.70022
8
Horia Minea, Ana-Maria Singeap, Manuela Minea, Simona Juncu, Cristina Muzica, Catalin Victor Sfarti, Irina Girleanu, Stefan Chiriac, Ioana Diandra Miftode, Carol Stanciu, Anca Trifan. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(15) doi: 10.3390/ijms25158420
9
Linlin Zheng, Anqi Cui, Jianing Shang, Fu Liu, Xiaoyu Zhang, Xue Dou, Jieyu Liu, Yunwei Li. Shen-Ling-Bai-Zhu-San alleviates Crohn's disease-like colitis by modulating fatty acid degradation via the peroxisome proliferation-activated receptor pathway: An integrated approach combining network pharmacology, microbiomics, metabolomics, proteomics, and experimental validation. Journal of Ethnopharmacology 2025; 353 doi: 10.1016/j.jep.2025.120460
10
Chahat Suri, Babita Pande, Tarun Sahu, Lakkakula Suhasini Sahithi, Henu Kumar Verma. Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects. Journal of Clinical Medicine 2024; 13(13) doi: 10.3390/jcm13133977
11
Parvin Zarei, Peyman Adibi Sedeh, Ahmad Vaez, Ammar Hassanzadeh Keshteli. Using metabolomics to investigate the relationship between the metabolomic profile of the intestinal microbiota derivatives and mental disorders in inflammatory bowel diseases: a narrative review. Research in Pharmaceutical Sciences 2025; 20(1) doi: 10.4103/RPS.RPS_273_23
12
Claudio Fiocchi. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914912
13
Xiaoyu Cai, Yao Yao, Yongquan Zheng, Xuezhi Zhao. Multi-omics gut microbiome signatures for treat-to-target management in inflammatory bowel disease. Microbiological Research 2026; 309 doi: 10.1016/j.micres.2026.128511
14
Xinyu Zhang, Yuan Li, Ping Li, Yunze Liu, Junmei Zhang, Jingwei Wu, Qi Wang, Xia Ding. Treatment of active ulcerative colitis with Yinmei Kuijie decoction combined with 5-aminosalicylic acid: A non-randomized multicenter prospective observational protocol based on real-world conditions. Journal of Traditional Chinese Medical Sciences 2024; 11(4) doi: 10.1016/j.jtcms.2024.05.001
15
Orazio Palmieri, Anna Lucia Cannarozzi, Anna Latiano, Luca Massimino, Fabrizio Bossa, Matteo Riva, Federica Ungaro, Maria Guerra, Anna Laura Pia Di Brina, Sonia Carparelli, Gionata Fiorino, Francesco Perri, Silvio Danese. Machine learning approach and internet of things technologies to unravel the complex interaction between microbiome-metabolome in inflammatory bowel disease: a new frontier in precision medicine. Gut Pathogens 2025; 17(1) doi: 10.1186/s13099-025-00758-5
16
Marek Vebr, Renáta Pomahačová, Josef Sýkora, Jan Schwarz. A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. Biomedicines 2023; 11(12) doi: 10.3390/biomedicines11123229
17
Yuhua Chen, Chao Huang, Fan Du, Zhuanglong Xiao, Wei Qian, Tao Bai, Jun Song, Yuhu Song, Xiaohua Hou, Lei Zhang. EphB2 promotes enteric nitrergic hyperinnervation and neurogenic inflammation in DSS-induced chronic colitis in mice. International Immunopharmacology 2024; 129 doi: 10.1016/j.intimp.2024.111591
18
Beata Jabłońska, Sławomir Mrowiec. Gastrointestinal Disease: New Diagnostic and Therapeutic Approaches. Biomedicines 2023; 11(5) doi: 10.3390/biomedicines11051420
19
Petar Uchikov, Usman Khalid, Nikola Vankov, Maria Kraeva, Krasimir Kraev, Bozhidar Hristov, Milena Sandeva, Snezhanka Dragusheva, Dzhevdet Chakarov, Petko Petrov, Bistra Dobreva-Yatseva, Ivan Novakov. The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis. Diagnostics 2024; 14(10) doi: 10.3390/diagnostics14101004
20
Ahmed Abu-Siniyeh, Moayad Khataibeh, Walid Al-Zyoud, Majed Al Holi. Zebrafish as a model for human epithelial pathology. Laboratory Animal Research 2025; 41(1) doi: 10.1186/s42826-025-00238-6
21
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Piero Portincasa. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Internal and Emergency Medicine 2023; 18(8) doi: 10.1007/s11739-023-03343-3
22
Liyun Xu, Yiting Xiao, Yuan Jiang, Jie Deng, Wenchao Xie, Zixian Luo, Qian Wang, Zhangrui Zeng, Jinbo Liu. The dual role of CCL20 in inflammatory disease: Maintenance of host defense and immunopathological balance. Pathology - Research and Practice 2026; 286 doi: 10.1016/j.prp.2026.156586
23
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
24
Darragh Barry, Cassandra Thachuk, Jackie Trink. Integrating gut microbiome and host transcriptomics for the personalized management of IBD. Epigenomics 2025; 17(18) doi: 10.1080/17501911.2025.2591594
25
Wassan Nori Mohammed Hassan, Methaq Mueen Al-kaabi, Nabeeha Najatee Akram, Mustafa Ali Kassim Kassim, Alexandru Cosmin Pantazi. Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks. Current Medicinal Chemistry 2024; 31(30) doi: 10.2174/0109298673314861240429072352
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.